NIH Weekly Funding Opportunities and Policy Notices

Wednesday, March 20, 2019 - 8:43am
Notice NOT-GM-19-026 from the NIH Guide for Grants and Contracts
Tuesday, March 19, 2019 - 6:36am
Funding Opportunity RFA-FD-19-018 from the NIH Guide for Grants and Contracts. The intended outcome of this cooperative agreement is to advance the goal of a national food safety system by supporting and enhancing state food laboratories tasked with investigation of foodborne disease outbreaks in activities including: 1. Ensuring microbiological and chemical food analyses performed on behalf of the State manufactured food regulatory programs are conducted within the scope of an International Organization for Standardization (ISO)/ International Electrotechnical Commission (IEC) 17025 accredited laboratory; 2. Strengthening the collaboration between the laboratories and State manufactured food regulatory programs; 3. Increasing the number of State samples collected and analyzed for surveillance purposes annually; 4. Developing a stronger international rapid surveillance system for pathogen traceback through the GenomeTrakr network using a minimum set of metadata fields for all food and environmental isolates; and 5. Providing additional support to the State food laboratories through an outside association to offer trainings, workshops, and educational resources to both awardees under this cooperative agreement and to unfunded laboratories seeking ISO/IEC 17025 accreditation.
Tuesday, March 19, 2019 - 6:22am
Notice NOT-LM-19-003 from the NIH Guide for Grants and Contracts
Tuesday, March 19, 2019 - 12:39am
Funding Opportunity PAR-19-225 from the NIH Guide for Grants and Contracts. The Transitions to Independent Environmental Health (TIEHR) Career Award is a 3-year bridge scholar career development program for newly independent faculty (within the first three years of their first independent faculty appointment) who intend to pursue research careers in the environmental health sciences. The award provides salary support and pilot funding during this critical period so that the candidate can further develop their research program and, subsequently, successfully compete for research funding in the environmental health sciences at the completion of the award.
Monday, March 18, 2019 - 11:50pm
Notice NOT-GM-19-029 from the NIH Guide for Grants and Contracts
Monday, March 18, 2019 - 10:24am
Funding Opportunity RFA-HD-20-005 from the NIH Guide for Grants and Contracts. In this funding opportunity announcement (FOA), the National Center for Medical Rehabilitation Research within NICHD invites applications for research project grants addressing the rehabilitation needs of children with chronic, physical disabilities.
Monday, March 18, 2019 - 10:01am
Funding Opportunity RFA-AI-19-015 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Atopic Dermatitis Research Network Clinical Research Centers (ADRN-CRCs). The ADRN-CRCs will conduct the ADRN network-wide clinical research projects under the leadership of the ADRN Leadership Center (ADRN-LC). In parallel, each ADRN-CRC will pursue its own clinical research program in support of the scientific goals of the ADRN. To achieve the ADRN objectives, the ADRN-CRCs will work closely with the ADRN-LC.
Monday, March 18, 2019 - 10:01am
Funding Opportunity RFA-AI-19-014 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Atopic Dermatitis Research Network Leadership Center (ADRN-LC) for the NIAID ADRN. The ADRN-LC will provide the overall scientific strategy and organizational structure to the ADRN and will interact closely with the ADRN Clinical Research Centers (ADRN-CRCs), to support the conduct of multi-site clinical studies and trials under the ADRN.
Monday, March 18, 2019 - 9:31am
Funding Opportunity PAR-19-223 from the NIH Guide for Grants and Contracts. Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.
Monday, March 18, 2019 - 8:12am
Funding Opportunity PAR-19-222 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide support for New Investigators from backgrounds nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The R21 is intended to support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition to research independence of New Investigators from backgrounds underrepresented in the biomedical and behavioral sciences. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Friday, March 15, 2019 - 10:03am
Funding Opportunity RFA-AI-19-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control.
Friday, March 15, 2019 - 10:03am
Funding Opportunity RFA-AI-19-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include HIV/AIDS and HIV/AIDS-associated malignancies.
Friday, March 15, 2019 - 9:38am
Notice NOT-NS-19-045 from the NIH Guide for Grants and Contracts
Thursday, March 14, 2019 - 11:52pm
Notice NOT-CA-19-035 from the NIH Guide for Grants and Contracts
Thursday, March 14, 2019 - 11:20pm
Funding Opportunity RFA-AI-19-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include HIV/AIDS and HIV/AIDS-associated malignancies. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the laboratories and clinics of the NIH) and eligible South African investigators (e.g., those conducting research in eligible laboratories in South Africa). In order to be eligible for this program, the application must include at least one NIH IRP investigator serving as a Project Scientist with an equal role in the conceptualization, design and execution of the research.
Thursday, March 14, 2019 - 11:20pm
Funding Opportunity RFA-AI-19-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the laboratories and clinics of the NIH) and eligible South African investigators (e.g., those conducting research in eligible laboratories in South Africa). In order to be eligible for this program, the application must include at least one NIH IRP investigator serving as a Project Scientist with an equal role in the conceptualization, design and execution of the research.
Thursday, March 14, 2019 - 10:59am
Notice NOT-RM-19-004 from the NIH Guide for Grants and Contracts
Thursday, March 14, 2019 - 10:53am
Notice NOT-GM-19-028 from the NIH Guide for Grants and Contracts

Pages